Ono Pharmaceutical Co Ltd (OPHLY)
4.542
-0.01
(-0.18%)
USD |
OTCM |
Jul 01, 15:59
Ono Pharmaceutical Enterprise Value: 5.097B for June 28, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| June 28, 2024 | 5.097B |
| June 27, 2024 | 5.125B |
| June 26, 2024 | 5.097B |
| June 25, 2024 | 5.210B |
| June 24, 2024 | 5.136B |
| June 21, 2024 | 4.928B |
| June 20, 2024 | 4.885B |
| June 18, 2024 | 4.985B |
| June 17, 2024 | 5.040B |
| June 14, 2024 | 4.970B |
| June 13, 2024 | 4.998B |
| June 12, 2024 | 5.139B |
| June 11, 2024 | 5.195B |
| June 10, 2024 | 5.379B |
| June 07, 2024 | 5.350B |
| June 06, 2024 | 5.350B |
| June 05, 2024 | 5.407B |
| June 04, 2024 | 5.487B |
| June 03, 2024 | 5.379B |
| May 31, 2024 | 5.407B |
| May 30, 2024 | 5.210B |
| May 29, 2024 | 5.125B |
| May 28, 2024 | 5.266B |
| May 24, 2024 | 5.280B |
| May 23, 2024 | 5.336B |
| Date | Value |
|---|---|
| May 22, 2024 | 5.379B |
| May 21, 2024 | 5.520B |
| May 20, 2024 | 5.548B |
| May 17, 2024 | 5.466B |
| May 16, 2024 | 5.435B |
| May 15, 2024 | 5.646B |
| May 14, 2024 | 5.604B |
| May 13, 2024 | 5.562B |
| May 10, 2024 | 5.534B |
| May 09, 2024 | 5.534B |
| May 08, 2024 | 5.576B |
| May 07, 2024 | 5.590B |
| May 06, 2024 | 5.682B |
| May 03, 2024 | 5.675B |
| May 02, 2024 | 5.632B |
| May 01, 2024 | 5.534B |
| April 30, 2024 | 5.350B |
| April 29, 2024 | 5.562B |
| April 26, 2024 | 5.534B |
| April 25, 2024 | 5.435B |
| April 24, 2024 | 5.576B |
| April 23, 2024 | 5.576B |
| April 22, 2024 | 5.604B |
| April 19, 2024 | 5.435B |
| April 18, 2024 | 5.562B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
4.885B
Minimum
Jun 20 2024
15.26B
Maximum
Sep 17 2020
10.18B
Average
10.31B
Median
Enterprise Value Benchmarks
| Takeda Pharmaceutical Co Ltd | 69.49B |
| Nxera Pharma Co Ltd | 983.06M |
| PeptiDream Inc | 1.815B |
| Healios KK | 83.01M |
| AnGes Inc | 59.01M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 117.46M |
| Revenue (Quarterly) | 759.81M |
| Total Expenses (Quarterly) | 656.66M |
| EPS Diluted (Quarterly) | 0.0842 |
| Gross Profit Margin (Quarterly) | 71.92% |
| Profit Margin (Quarterly) | 15.46% |
| Earnings Yield | 13.58% |
| Operating Earnings Yield | 17.00% |
| Normalized Earnings Yield | 13.58 |